» Authors » Julien Ternacle

Julien Ternacle

Explore the profile of Julien Ternacle including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 126
Citations 1174
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Massie C, Dube F, Sridi-Cheniti S, Ternacle J, Lafitte S, Reant P
Arch Cardiovasc Dis . 2025 Mar; PMID: 40069068
Background: Patients with left ventricular hypertrophy (LVH) often maintain preserved left ventricular ejection fraction in the early stages of the disease. There is a need to identify simple and reliable...
2.
Silva I, Alperi A, Munoz A, Cheema A, Nombela L, Veiga-Fernandez G, et al.
Eur Heart J Cardiovasc Imaging . 2025 Mar; PMID: 40059432
Aims: Valve durability becomes a major issue as transcatheter aortic valve implantation (TAVI) is expanding to populations with longer life expectancy. We sought to i) determine the incidence of structural...
3.
Hahn R, Pibarot P, Abbas A, Makkar R, Thourani V, Genereux P, et al.
JACC Cardiovasc Interv . 2025 Feb; 18(4):506-517. PMID: 40010919
Background: Short-term clinical outcomes after transcatheter aortic valve replacement (TAVR) are similar in individuals with small or large annuli. The longer term impact of prosthesis-patient mismatch (PPM) and mean gradient...
4.
Giuliani C, Zanuttini A, Hecht S, Ternacle J, Pibarot P
Curr Cardiol Rep . 2025 Feb; 27(1):49. PMID: 39928182
Purpose Of Review: Prosthesis-patient mismatch (PPM) remains a significant concern in valve intervention. This review highlights the current evidence surrounding PPM, compares its impact after surgical aortic valve replacement (SAVR)...
5.
Baudo M, Cuko B, Ternacle J, Sicouri S, Busuttil O, Denti P, et al.
Cardiovasc Interv Ther . 2025 Jan; 40(2):255-267. PMID: 39838219
Background: Treatment of residual mitral regurgitation (MR) with different percutaneous devices after transcatheter edge-to-edge repair (TEER) has been reported as an alternative option to reclipping or surgery. This review aims...
6.
Modine T, Leroux L, Ternacle J
JACC Cardiovasc Interv . 2025 Jan; 18(1):100-102. PMID: 39814483
No abstract available.
7.
Gonzalvez-Garcia A, Cepas-Guillen P, Ternacle J, Urena M, Alperi A, Cheema A, et al.
Rev Esp Cardiol (Engl Ed) . 2024 Dec; PMID: 39722415
Introduction And Objectives: The Valve Academic Research Consortium (VARC)-3 definition of the early safety (ES) composite endpoint after transcatheter aortic valve replacement (TAVR) lacks clinical validation. The aim of this...
8.
Nuche J, Mesnier J, Ternacle J, Rezaei E, Campelo-Parada F, Urena M, et al.
Can J Cardiol . 2024 Dec; PMID: 39710301
Background: Patients with symptomatic aortic stenosis are a vulnerable population with associated cardiac damage and a significant comorbidity burden. In this study we aimed to determine the rate, factors associated...
9.
Thourani V, Leon M, Makkar R, Ascione G, Szeto W, Madhavan M, et al.
Ann Thorac Surg . 2024 Dec; 119(3):555-566. PMID: 39694217
Background: Surgery remains an important treatment for low-risk patients with severe symptomatic aortic stenosis (AS). This study evaluated 5-year outcomes in low-risk patients undergoing isolated surgical aortic valve replacement (SAVR)...
10.
Mengi S, Cepas-Guillen P, Cepas-Guillen P, Ternacle J, Urena M, Alperi A, et al.
Can J Cardiol . 2024 Dec; PMID: 39667494
Background: Atrial fibrillation (AF) has been identified as a marker of advanced cardiac damage in patients with aortic stenosis. However, the factors associated with poorer outcomes among AF patients in...